Mannino DM, Buist AS (2007) Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370(9589):765–773
Article
Google Scholar
McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG et al (2011) Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 365(17):1567–1575
Article
CAS
Google Scholar
Han MK, Kazerooni EA, Lynch DA, Liu LX, Murray S, Curtis JL et al (2011) Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology 261(1):274–282
Article
Google Scholar
Aaron CP, Schwartz JE, Hoffman EA, Angelini E, Austin JHM, Cushman M et al (2018) A longitudinal cohort study of aspirin use and progression of emphysema-like lung characteristics on ct imaging: the MESA Lung Study. Chest 154(1):41–50
Article
Google Scholar
Iyer AS, Wells JM, Vishin S, Bhatt SP, Wille KM, Dransfield MT (2014) CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD. Chest 145(4):824–832
Article
Google Scholar
Hueper K, Vogel-Claussen J, Parikh MA, Austin JH, Bluemke DA, Carr J et al (2015) Pulmonary microvascular blood flow in mild chronic obstructive pulmonary disease and emphysema. The MESA COPD Study. Am J Respir Crit Care Med 192(5):570–580
Article
CAS
Google Scholar
Nakano Y, Muro S, Sakai H, Hirai T, Chin K, Tsukino M et al (2000) Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 162(3 Pt 1):1102–1108
Article
CAS
Google Scholar
Bushberg JT, Seibert JA, Leidholdt EM, Boone JM, Mahesh M (2013) The essential physics of medical imaging, third edition. Med Phys 40(7):077301
Article
Google Scholar
Ostridge K, Williams NP, Kim V, Harden S, Bourne S, Clarke SC et al (2018) Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD. Respir Res 19(1):31
Article
Google Scholar
Hoffman EA, Lynch DA, Barr RG, van Beek EJ, Parraga G, Investigators I (2016) Pulmonary CT and MRI phenotypes that help explain chronic pulmonary obstruction disease pathophysiology and outcomes. J Magn Reson Imaging 43(3):544–557
Article
Google Scholar
Alford SK, van Beek EJR, McLennan G, Hoffman EA (2010) Heterogeneity of pulmonary perfusion as a mechanistic image-based phenotype in emphysema susceptible smokers. Proc Natl Acad Sci U S A 107(16):7485–7490
Article
CAS
Google Scholar
Estepar RS, Kinney GL, Black-Shinn JL, Bowler RP, Kindlmann GL, Ross JC et al (2013) Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. Am J Respir Crit Care Med 188(2):231–239
Article
Google Scholar
Pike D, Kirby M, Guo F, McCormack DG, Parraga G (2015) Ventilation heterogeneity in ex-smokers without airflow limitation. Acad Radiol 22(8):1068–1078
Article
Google Scholar
van Beek EJR, Dahmen AM, Stavngaard T, Gast KK, Heussel CP, Krummenauer F et al (2009) Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial. Eur Respir J 34(6):1311–1321
Article
Google Scholar
Mugler JP, Altes TA, Ruset IC, Dregely IM, Mata JF, Miller GW et al (2010) Simultaneous magnetic resonance imaging of ventilation distribution and gas uptake in the human lung using hyperpolarized xenon-129. Proc Natl Acad Sci U S A 107(50):21707–21712
Article
CAS
Google Scholar
Qing K, Shim YM, Tustison NJ, Altes TA, Ruppert K, Mata JF, et al. Hyperpolarized xenon-129 MRI: a new tool to evaluate COPD. American Thoracic Society; 2016; p A1049
Ohno Y, Hatabu H (2007) Basics concepts and clinical applications of oxygen-enhanced MR imaging. Eur J Radiol 64(3):320–328
Article
Google Scholar
Fuseya Y, Muro S, Sato S, Tanabe N, Sato A, Tanimura K et al (2018) Complementary regional heterogeneity information from COPD patients obtained using oxygen-enhanced MRI and chest CT. PLoS ONE 13(8):e0203273
Article
Google Scholar
Izquierdo-Alonso JL, Rodriguez-Gonzálezmoro JM, de Lucas-Ramos P, Unzueta I, Ribera X, Antón E et al (2013) Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD). Respir Med 107(5):724–731
Article
Google Scholar
Márquez-Martín E, Ramos PC, López-Campos JL, del Serrano Gotarredona M P, Herrero SN, Aguilar RT et al (2011) Components of physical capacity in patients with chronic obstructive pulmonary disease: relationship with phenotypic expression. Int J Chron Obstruct Pulmon Dis 6:105–112
Article
Google Scholar
Paige M, Burdick MD, Kim S, Xu J, Lee JK, Shim YM (2011) Pilot analysis of the plasma metabolite profiles associated with emphysematous Chronic Obstructive Pulmonary Disease phenotype. Biochem Biophys Res Commun 413(4):588–593
Article
CAS
Google Scholar
Carolan BJ, Hughes G, Morrow J, Hersh CP, O’Neal WK, Rennard S et al (2014) The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes. Respir Res 15:127
Article
Google Scholar
Nakamura M, Nakamura H, Minematsu N, Chubachi S, Miyazaki M, Yoshida S et al (2014) Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease. Biomarkers 19(5):368–377
Article
CAS
Google Scholar
Golpe R, Sanjuán López P, Cano Jiménez E, Castro Añón O, Pérez de Llano LA (2014) Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke. Arch Bronconeumol 50(8):318–324
Article
Google Scholar
Kim V, Davey A, Comellas AP, Han MK, Washko G, Martinez CH et al (2014) Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study. Respir Res 15:52
Article
Google Scholar
Jones H (2002) Kinetics of lung macrophages monitored in vivo following particulate challenge in rabbits. Toxicol Appl Pharmacol 183(1):46–54
Article
CAS
Google Scholar
Jones HA, Marino PS, Shakur BH, Morrell NW (2003) In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma. Eur Respir J 21(4):567–573
Article
CAS
Google Scholar
Subramanian DR, Jenkins L, Edgar R, Quraishi N, Stockley RA, Parr DG (2012) Assessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomography. Am J Respir Crit Care Med 186(11):1125–1132
Article
Google Scholar
Faner R, Cruz T, Agustí A (2013) Immune response in chronic obstructive pulmonary disease. Expert Rev Clin Immunol. 9(9):821–833
Article
Google Scholar
Jörgensen K, Müller MF, Nel J, Upton RN, Houltz E, Ricksten S-E (2007) Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI study. Chest 131(4):1050–1057
Article
Google Scholar
Jögi J, Ekberg M, Jonson B, Bozovic G, Bajc M (2011) Ventilation/perfusion SPECT in chronic obstructive pulmonary disease: an evaluation by reference to symptoms, spirometric lung function and emphysema, as assessed with HRCT. Eur J Nucl Med Mol Imaging 38(7):1344–1352
Article
Google Scholar
Golestani R, Razavian M, Ye Y, Zhang J, Jung J-J, Toczek J et al (2017) Matrix metalloproteinase-targeted imaging of lung inflammation and remodeling. J Nucl Med 58(1):138–143
Article
CAS
Google Scholar
Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K et al (2009) A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b, d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408). J Med Chem 52(7):1799–1802
Article
Google Scholar
Kondo N, Temma T, Aita K, Shimochi S, Koshino K, Senda M et al (2018) Development of matrix metalloproteinase-targeted probes for lung inflammation detection with positron emission tomography. Sci Rep 8(1):1347
Article
Google Scholar
Esteban C, Quintana JM, Moraza J, Aburto M, Aguirre U, Aguirregomoscorta JI et al (2010) BODE-Index vs HADO-score in chronic obstructive pulmonary disease: which one to use in general practice? BMC Med 8:28
Article
Google Scholar
Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA et al (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350(10):1005–1012
Article
CAS
Google Scholar
Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P et al (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176(6):532–555
Article
Google Scholar
Gold Reports 2018 [Internet]. Global initiative for chronic obstructive lung disease—GOLD. https://goldcopd.org/gold-reports/. Accessed 16 Oct 2018
Wells JM, Washko GR, Han MK, Abbas N, Nath H, Mamary AJ et al (2012) Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med 367(10):913–921
Article
CAS
Google Scholar
Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R et al (2010) Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363(12):1128–1138
Article
CAS
Google Scholar
Johannessen A, Skorge TD, Bottai M, Grydeland TB, Nilsen RM, Coxson H et al (2013) Mortality by level of emphysema and airway wall thickness. Am J Respir Crit Care Med 187(6):602–608
Article
Google Scholar
Lynch DA, Moore CM, Wilson C, Nevrekar D, Jennermann T, Humphries SM et al (2018) CT-based visual classification of emphysema: association with mortality in the COPD Gene Study. Radiology 288:859–866
Article
Google Scholar
Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A et al (2003) A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 348(21):2059–2073
Article
Google Scholar
Sciurba FC, Ernst A, Herth FJ, Strange C, Criner GJ, Marquette CH et al (2010) A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 363(13):1233–1244
Article
CAS
Google Scholar
Kim V, Desai P, Newell JD, Make BJ, Washko GR, Silverman EK et al (2014) Airway wall thickness is increased in COPD patients with bronchodilator responsiveness. Respir Res 15:84
Article
CAS
Google Scholar
De Luca N, Capuzi P, D’Angeli AL, D’Antoni L, Pavone P, De Santis M et al (1999) High resolution computed tomography (HRCT) assessment of beta 2-agonist induced bronchodilation in chronic obstructive pulmonary disease patients. Eur Rev Med Pharmacol Sci 3(2):83–87
PubMed
Google Scholar
Kirby M, Mathew L, Heydarian M, Etemad-Rezai R, McCormack DG, Parraga G (2011) Chronic obstructive pulmonary disease: quantification of bronchodilator effects by using hyperpolarized (3)He MR imaging. Radiology 261(1):283–292
Article
Google Scholar
Iyer KS, Newell JD Jr, Jin D, Fuld MK, Saha PK, Hansdottir S et al (2016) Quantitative dual-energy computed tomography supports a vascular etiology of smoking-induced inflammatory lung disease. Am J Respir Crit Care Med 193(6):652–661
Article
CAS
Google Scholar
Lee SM, Kim SS, Hwang HJ, Seo JB. Imaging of COPD. In: COPD [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 2017. p 87–127
Chapter
Google Scholar
Chapman KR, Burdon JG, Piitulainen E, Sandhaus RA, Seersholm N, Stocks JM et al (2015) Intravenous augmentation treatment and lung density in severe alpha1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial. Lancet 386(9991):360–368
Article
CAS
Google Scholar
Stockley RA, Parr DG, Piitulainen E, Stolk J, Stoel BC, Dirksen A (2010) Therapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry. Respir Res 11:136
Article
Google Scholar
Dimastromatteo J, Charles EJ, Laubach VE (2018) Molecular imaging of pulmonary diseases. Respir Res 19(1):17
Article
Google Scholar